Abvc Biopharma (ABVC) Income from Non-Controlling Interests (2018 - 2025)
Historic Income from Non-Controlling Interests for Abvc Biopharma (ABVC) over the last 8 years, with Q3 2025 value amounting to -$41010.0.
- Abvc Biopharma's Income from Non-Controlling Interests rose 5574.24% to -$41010.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$283889.0, marking a year-over-year increase of 5332.21%. This contributed to the annual value of -$356159.0 for FY2024, which is 2772.66% up from last year.
- According to the latest figures from Q3 2025, Abvc Biopharma's Income from Non-Controlling Interests is -$41010.0, which was up 5574.24% from -$75811.0 recorded in Q2 2025.
- Over the past 5 years, Abvc Biopharma's Income from Non-Controlling Interests peaked at $1.0 million during Q4 2021, and registered a low of -$316981.0 during Q4 2023.
- Over the past 5 years, Abvc Biopharma's median Income from Non-Controlling Interests value was -$75811.0 (recorded in 2025), while the average stood at -$8108.5.
- In the last 5 years, Abvc Biopharma's Income from Non-Controlling Interests skyrocketed by 95305.54% in 2021 and then tumbled by 18731.39% in 2023.
- Over the past 5 years, Abvc Biopharma's Income from Non-Controlling Interests (Quarter) stood at $1.0 million in 2021, then plummeted by 64.79% to $363036.0 in 2022, then tumbled by 187.31% to -$316981.0 in 2023, then skyrocketed by 79.51% to -$64953.0 in 2024, then soared by 36.86% to -$41010.0 in 2025.
- Its Income from Non-Controlling Interests was -$41010.0 in Q3 2025, compared to -$75811.0 in Q2 2025 and -$102115.0 in Q1 2025.